CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.

ABSTRACT:

Background

Due to the great heterogeneity of gastric cancer (GC), the prognosis of patients within a stage is very different. Therefore, it is necessary to identify the high risk factors for postoperative recurrence and metastasis and take appropriate therapeutic strategies to improve the prognosis of patients. In this study, we aimed to explore the prognostic significance of preoperative and postoperative serum carcinoembryonic antigen (CEA), carbohydrate antigen 19 - 9 (CA19-9) and carbohydrate antigen 72 - 4 (CA72-4) in patients with stage I, II and III GC who underwent radical gastrectomy.

Methods

A total of 580 patients who underwent curative surgical resection and had not received neoadjuvant chemotherapy were included in this study. The relationship between clinicopat

SUBMITTER: Ma X 

PROVIDER: S-EPMC10804529 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature